the Effect of a New Type of Pelvic Floor Rehabilitation Device PHENIX U4+ on the Treatment of Urinary Incontinence
Urinary Incontinence
About this trial
This is an interventional treatment trial for Urinary Incontinence focused on measuring new type of pelvic floor rehabilitation device PHENIX U4+, Traditional pelvic floor electrical stimulation therapy instrument
Eligibility Criteria
Inclusion Criteria:1) 18 years old and above; 2) Have a history of sexual life; 3) Plan to live locally for a long time; 4) Mild to moderate pressure, urgency or mixed urinary incontinence; 5) The patient agrees to conduct the study and signs an informed consent form.
Exclusion Criteria:
- Combined pelvic organ prolapse (with extrahymen bulging);
- Obesity (BMI>28kg/m2, BMI=weight (kg)/height square (m2));
- Uncontrolled asthma and chronic obstructive pulmonary disease (COPD);
- Combined connective tissue disease;
- Women with unclean lochia during pregnancy, within 6 weeks of postpartum and postpartum
- Malignant tumors;
- Combined neurological diseases (patients with epilepsy and dementia);
- Those with a synchronized pacemaker on their chest (biofeedback can be done).
Sites / Locations
- Peking University People's Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
PHENIX U4+
Traditional pelvic floor electrical stimulation therapy instrument
Electrical stimulation treatment for patients with urinary incontinence using a new type of pelvic floor therapy instrument
Electrical stimulation treatment for patients with urinary incontinence using traditional pelvic floor therapy instrument